Vulvar Cancer Global Clinical Trials Review, H1, 2014

Date: April 24, 2014
Pages: 85
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: VBC432E6A66EN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2014' provides data on the Vulvar Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vulvar Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Vulvar Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Vulvar Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Vulvar Cancer to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Vulvar Cancer to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Vulvar Cancer
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Vulvar Cancer Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Vulvar Cancer
Nov 05, 2009: ISA Pharmaceuticals Announces NEJM Publication On VIN Phase II Data
Apr 21, 2008: Graceway Pharmaceuticals Reports Study in New England Journal of Medicine: Aldara (imiquimod) Cream, 5% demonstrated a reduction in lesion size in patients with vulvar intraepithelial neoplasia (VIN).
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
ISA Pharmaceuticals B.V.
Clinical Trial Overview of ISA Pharmaceuticals B.V.
Precision Therapeutics, Inc.
Clinical Trial Overview of Precision Therapeutics, Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Burzynski Research Institute, Inc.
Clinical Trial Overview of Burzynski Research Institute, Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
Gynecologic Oncology Group
Clinical Trial Overview of Gynecologic Oncology Group
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Women and Infants Hospital of Rhode Island
Clinical Trial Overview of Women and Infants Hospital of Rhode Island
Leiden University Medical Center
Clinical Trial Overview of Leiden University Medical Center
Northwestern University
Clinical Trial Overview of Northwestern University
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Erasmus MC
Clinical Trial Overview of Erasmus MC
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Vulvar Cancer Therapeutics, Global, Clinical Trials by Region, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Vulvar Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014
Vulvar Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014
Vulvar Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Vulvar Cancer to Oncology Clinical Trials, G7 Countries (%), 2014
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Vulvar Cancer to Oncology Clinical Trials, E7 Countries (%), 2014
Vulvar Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials by Phase, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014
Vulvar Cancer Therapeutics, Global, Suspended Clinical Trials, 2014
Vulvar Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014
Vulvar Cancer Therapeutics, Global, Terminated Clinical Trials, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ISA Pharmaceuticals B.V., 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Women and Infants Hospital of Rhode Island, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014
Vulvar Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014

LIST OF FIGURES

Vulvar Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Vulvar Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Vulvar Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Vulvar Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Vulvar Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Vulvar Cancer to Oncology Clinical Trials, G7 Countries (%), 2014
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Vulvar Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Vulvar Cancer to Oncology Clinical Trials, E7 Countries (%), 2014
Vulvar Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Vulvar Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Vulvar Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Vulvar Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Ask Your Question

Vulvar Cancer Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: